G 0522 G 0522 (Fenofibrate (micronized) 134 mg)
Pill imprint G 0522 G 0522 has been identified as Fenofibrate (micronized) 134 mg.
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 134 mg is not a controlled substance under the Controlled Substance Act (CSA).
- G 0522 G 0522
- 134 mg
- 19.00 mm
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Global Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|68084-0835||Amerisource Health Services|
|54868-5994||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about fenofibrate
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.